• Angiotensin I/II (1-5): Protocol Guide

  2026-08-17

  This guide explains how to use Angiotensin I/II (1-5), a defined Asp-Arg-Val-Tyr-Ile peptide fragment, in renin-angiotensin system research involving cardiovascular, renal, blood pressure, or aldosterone-related endpoints. It is not intended for unrelated signaling studies, and its insolubility in water requires deliberate solvent selection and vehicle controls.

• Trolox Workflows for Redox-Controlled Organoids

  2026-08-17

  Trolox provides a practical redox-control layer for organoid culture, oxidative injury research, and antioxidant assay benchmarking. This guide combines solvent-aware dosing, organoid-compatible workflow design, and troubleshooting strategies to distinguish genuine cytoprotection from assay artifacts.

• Bafilomycin C1: Designing Smarter Flux Assays

  2026-08-16

  Bafilomycin C1 is a vacuolar H+-ATPases inhibitor that can turn lysosomal acidification into a measurable experimental variable. This guide connects V-ATPase biology with high-content phenotyping, autophagy assay design, and the deep-learning strategy used in iPSC-cardiomyocyte screening.

• Vincristine Sulfate: Assay Design Through Mechanistic Lenses

  2026-08-15

  Vincristine sulfate is a powerful tool for cancer research, but its microtubule mechanism requires careful separation of cytotoxicity from downstream inflammatory signals. This article applies a systematic-review framework to improve assay interpretation, controls, and translational relevance.

• ML365, NLRP3, and Cognitive Impairment in Aged Mice

  2026-08-14

  A 2024 Brain Research study reports that ML365 pretreatment reduced postoperative cognitive impairment in aged mice after exploratory laparotomy, alongside lower hippocampal NLRP3 inflammasome signaling, tissue injury, and systemic oxidative stress. The work connects two-pore potassium-channel pharmacology with hippocampal neuroinflammation, while also leaving open whether the observed effects are specifically mediated by TASK1 inhibition.

• SR 11302 and the Translational Logic of AP-1 Blockade

  2026-08-14

  SR 11302 offers a retinoid-independent approach to studying AP-1-driven tumor biology. By connecting its selective antiproliferative profile with macrophage and TLR4 findings from a colitis-associated colorectal cancer study, researchers can design more discriminating experiments while avoiding premature claims about therapeutic efficacy.

• Wortmannin: PI3K Inhibitor Mechanism & Use

  2026-08-13

  Wortmannin is a selective and irreversible PI3K inhibitor used to interrogate PI3K/Akt/mTOR signaling, autophagy, apoptosis, and cancer biology. Product data report nanomolar PI3K potency, higher micromolar MLCK activity, DMSO solubility, and storage at −20°C.

• HRP Rabbit Anti-Goat IgG (H+L) Antibody Guide

  2026-08-13

  The HRP Rabbit Anti-Goat IgG (H+L) Antibody is a horseradish peroxidase conjugated secondary antibody for immunodetection of goat primary antibodies. Product-listed formulation, storage conditions, and application-specific dilution ranges support reproducible ELISA, western blot, dot blot, and tissue-staining workflows.

• Y-27632: From ROCK Biology to Translation

  2026-08-12

  Y-27632 offers a reversible, selective way to interrogate ROCK-dependent cytoskeletal behavior while opening a carefully bounded research bridge to the LPS/TLR4/YAP1 stemness axis described in hepatocytes. This thought-leadership perspective translates that mechanistic opportunity into experimental design, product-selection criteria, and translational strategy.

• Z-IETD-FMK: Reliable Caspase-8 Assays

  2026-08-12

  Learn how Z-IETD-FMK (SKU B3232) can help researchers distinguish caspase-8-dependent apoptosis from general metabolic decline, optimize T-cell assays, and interpret complex cell-death phenotypes. This scenario-based guide links formulation, controls, pathway biology, and vendor-selection considerations to practical laboratory decisions.

• Bafilomycin C1 in High-Content Cell Assays

  2026-08-11

  Bafilomycin C1 turns lysosomal acidification into a controllable experimental variable for autophagy, toxicity, and high-content phenotyping workflows. This guide pairs V-ATPase inhibition with iPSC-cardiomyocyte imaging, practical dose-finding, and troubleshooting strategies that help distinguish organelle stress from direct electrophysiological injury.

• Chlorambucil Workflows for Cancer Drug Response

  2026-08-11

  Build more informative Chlorambucil experiments by separating growth inhibition from actual cell killing. This workflow covers solvent handling, time-resolved viability and apoptosis measurements, model-specific interpretation, and troubleshooting for leukemia, glioma, and comparative cell studies.

• ECL Chemiluminescent Substrate Detection Kit Guide

  2026-08-09

  The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) supports HRP-based immunoblotting when low-abundance protein bands are difficult to visualize. It is intended for research use with nitrocellulose or PVDF membranes and should not be used for diagnostic, clinical, or medical applications.

• MG-262: Mapping Proteostasis in Inflamed Lung Cells

  2026-08-08

  MG-262, or Z-Leu-Leu-Leu-B(OH)2, enables reversible interrogation of proteasome function at the intersection of inflammation, ubiquitin signaling, and epithelial cell fate. This article translates cytokine and glucocorticoid findings into a mechanistically controlled proteasome inhibition assay strategy.

• (5Z)-7-Oxozeaenol in Stress-Signaling Assays

  2026-08-07

  Explore how the TAK1 inhibitor (5Z)-7-Oxozeaenol can clarify the AMPK–SQSTM1 stress-response circuit. This article translates recent mechanistic findings into assay-design decisions while distinguishing metabolic-stress evidence from inflammation applications.

15797 records 1/1054 page Next 12345 下5页 Last page